乳制品副产品用于乳制婴儿配方奶粉的价值化:营养视角审查
Duygu Ağagündüz1, Teslime Özge Şahin2, Elif Çelik3
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Ankara, Turkey.
Food research international (Ottawa, Ont.)
|January 9, 2026
概括
价值化乳制品副产品,如乳清蛋白和MFGM,可以可持续地提高婴儿配方奶粉的营养. 这些成分模仿母乳,支持婴儿发育和肠道健康,同时解决环境问题.
科学领域:
- 食品科学 食品科学 食品科学
- 营养科学 营养科学
- 生物技术是生物技术.
背景情况:
- 乳制品副产品为婴儿配方奶粉成分提供可持续的来源.
- 乳清蛋白,素,乳糖,GOS和MFGM等成分具有有益于婴儿健康的生物活性特性.
- 乳制品废物的利用与环境可持续性目标保持一致.
研究的目的:
- 审查乳制品副产品在婴儿营养中的潜力.
- 探索利用乳制品废弃物的方法,使其成为高价值的婴儿配方奶粉成分.
- 评估乳制品成分的功能性和生物活性性质.
主要方法:
- 关于乳制品副产品价值化和婴儿营养的科学文献的综述.
- 分析生物技术和物理化学方法 (例如,酶解水解,膜过).
- 对MFGM,GOS和水解乳清蛋白等成分的功能性质的评估.
主要成果:
- 乳制品的副产品可以加工成宝宝营养的宝贵成分.
- 多母生殖有助于神经发育,降低感染风险.
- 乳糖和GOS促进有益的肠道微生物群;水解乳清和A2β-素提供低过敏性益处.
结论:
- 乳制品副产品是改善婴儿配方奶粉的可持续方法.
- 在复制人类母乳复杂性方面仍然存在挑战,特别是MFGM结构和HMO多样性.
- 进一步的研究和监管评估对于优化和商业化这些组件至关重要.
相关概念视频
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
734
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
734
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
171
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
171
Proteins: Dietary Sources and Requirements
1.4K
Consuming animal-based products offers high-quality proteins that contain optimal levels and combinations of essential amino acids, crucial for tissue repair and growth. Foods like eggs, milk, fish, and most meats are a source of complete proteins. Legumes and cereals are abundant in proteins; however, they typically lack a full range of essential amino acids. As a result, they are considered incomplete protein sources. Some plant sources like soybeans, quinoa, and amaranth do contain complete...
1.4K
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
167
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
167
Bioavailability: Overview
350
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
350
Bioavailability: Overview
4.1K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.1K


